These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22496764)

  • 41. oxyR, a LysR-type regulator involved in Klebsiella pneumoniae mucosal and abiotic colonization.
    Hennequin C; Forestier C
    Infect Immun; 2009 Dec; 77(12):5449-57. PubMed ID: 19786563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.
    Gomez S; Pasteran F; Faccone D; Bettiol M; Veliz O; De Belder D; Rapoport M; Gatti B; Petroni A; Corso A
    Clin Microbiol Infect; 2013 May; 19(5):E233-5. PubMed ID: 23402333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The KP1_4563 gene is regulated by the cAMP receptor protein and controls type 3 fimbrial function in Klebsiella pneumoniae NTUH-K2044.
    Luo M; Yang S; Li X; Liu P; Xue J; Zhou X; Su K; Xu X; Qing Y; Qiu J; Li Y
    PLoS One; 2017; 12(7):e0180666. PubMed ID: 28732013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What does the susceptible-dose dependent interpretive category for cefepime in ESBL-producing bacteria?
    Menegucci TC; Bastos MS; Viana GF; Moreira RRB; Garcia LB; Cardoso CL; Tognim MCB
    J Chemother; 2017 Jun; 29(3):189-194. PubMed ID: 27077929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline.
    Hentschke M; Wolters M; Sobottka I; Rohde H; Aepfelbacher M
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2720-3. PubMed ID: 20350947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonal dissemination of multilocus sequence type 11 Klebsiella pneumoniae carbapenemase - producing K. pneumoniae in a Chinese teaching hospital.
    Sun K; Chen X; Li C; Yu Z; Zhou Q; Yan Y
    APMIS; 2015 Feb; 123(2):123-7. PubMed ID: 25257726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi.
    Grover SS; Sharma M; Pasha ST; Singh G; Lal S
    J Commun Dis; 2004 Mar; 36(1):17-26. PubMed ID: 16295682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
    Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
    Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China.
    Liang Y; Yin X; Zeng L; Chen S
    BMC Infect Dis; 2017 May; 17(1):363. PubMed ID: 28535790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergence of Klebsiella pneumoniae ST273 Carrying bla
    Chou A; Roa M; Evangelista MA; Sulit AK; Lagamayo E; Torres BC; Klinzing DC; Daroy ML; Navoa-Ng J; Sucgang R; Zechiedrich L
    Microb Drug Resist; 2016 Oct; 22(7):585-588. PubMed ID: 27032000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Pichardo C; Rodríguez-Martínez JM; Pachón-Ibañez ME; Conejo C; Ibáñez-Martínez J; Martínez-Martínez L; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3311-6. PubMed ID: 16048941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic and genotypic characterization of β-lactam resistance in Klebsiella pneumoniae isolated from swine.
    Zou LK; Wang HN; Zeng B; Zhang AY; Li JN; Li XT; Tian GB; Wei K; Zhou YS; Xu CW; Yang ZR
    Vet Microbiol; 2011 Apr; 149(1-2):139-46. PubMed ID: 21035968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
    Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
    Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Whole-genome sequence of a carbapenem-resistant hypermucoviscous Klebsiella pneumoniae isolate SWU01 with capsular serotype K47 belonging to ST11 from a patient in China.
    Zhang L; Li Y; Shen W; Wang SM; Wang G; Zhou Y
    J Glob Antimicrob Resist; 2017 Dec; 11():87-89. PubMed ID: 28893646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RamA upregulates multidrug resistance efflux pumps AcrAB and OqxAB in Klebsiella pneumoniae.
    Xu Q; Sheng Z; Hao M; Jiang J; Ye M; Chen Y; Xu X; Guo Q; Wang M
    Int J Antimicrob Agents; 2021 Feb; 57(2):106251. PubMed ID: 33259915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CadC regulates cad and tdc operons in response to gastrointestinal stresses and enhances intestinal colonization of Klebsiella pneumoniae.
    Hsieh PF; Lin HH; Lin TL; Wang JT
    J Infect Dis; 2010 Jul; 202(1):52-64. PubMed ID: 20497056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.